Latest Oblique Therapeutics News & Updates

See the latest news and media coverage for Oblique Therapeutics. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Oblique Therapeutics

Biotech developing antibodies for pain and cancer

obliquet.com
Headquarters
Göteborg, Sweden
Founded year
2015
Company type
Private company
Number of employees
2–10

Last updated

Latest news about Oblique Therapeutics

In short: Oblique Therapeutics raised capital through several share and convertible debt issuances while advancing its AbiProt technology and R&D programs.

Company announcements

Oblique Therapeutics

Oblique Therapeutics postpones the subscription period in the convertible issue

The reason is the delayed registration of the prospectus with the Financial Supervisory Authority. The terms are unchanged except for the maturity.

Unlock all announcements with a

Media coverage

Dagens industri

Oblique Therapeutics carries out an issue of convertibles of approximately 15.2 MSEK primarily directed to existing shareholders

Oblique Therapeutics has developed a patented technology, AbiProt®, with which one can identify areas on target proteins in the cell membrane where antibodies can bind. Information regarding these...

Unlock all articles with a

Never miss news about Oblique Therapeutics

Track Oblique Therapeutics and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.